Skip to content

Silicon Laboratories SLAB Debt Securities, Available-for-Sale And Cash Equivalents, Fair Value

Other financials

Income statement

See full
Revenue$213.5M+20.1%
Gross profit$127.0M+29.9%
Operating income-$17.1M+46.8%
Net income-$15.9M+47.8%
EPS (diluted)-$0.48+48.9%

Balance sheet

See full
Cash & equivalents$383.1M+17.9%
Total debt$24.0M+11.8%
Total equity$1.1B+2.8%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$4.9M-89.7%
CapEx$9.8M+103%
Free cash flow-$4.9M-111%

Valuation

See full
Market cap$7.25B+113%
P/S8.8×+3.6×

Profitability

See full
Gross margin59.3%+5.1pp
Operating margin-6.8%-2.7pp
Net margin-6.1%-2.6pp
FCF margin-6.3%-21.8pp

Returns & leverage

See full
Return on equity-4.6%-1.9pp
Debt / equity0.0×
Current ratio5.1×-0.1×

Where this comes from

Reported directly by Silicon Laboratories in its filing.

Tagged under the XBRL concept slab:DebtSecuritiesAvailableForSaleAndCashEquivalentsFairValue.

The official record: Silicon Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Silicon Laboratories's debt securities, available-for-sale and cash equivalents, fair value.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Silicon Laboratories's debt securities, available-for-sale and cash equivalents, fair value?
Silicon Laboratories (SLAB) reported debt securities, available-for-sale and cash equivalents, fair value of $278.47M in Q1 2026.
How has Silicon Laboratories's debt securities, available-for-sale and cash equivalents, fair value changed year-over-year?
Silicon Laboratories's debt securities, available-for-sale and cash equivalents, fair value decreased by 15.1% year-over-year, from $327.98M to $278.47M.
What is the long-term trend for Silicon Laboratories's debt securities, available-for-sale and cash equivalents, fair value?
Over 2 years (2023 to 2025), Silicon Laboratories's debt securities, available-for-sale and cash equivalents, fair value has grown at a -8.7% compound annual growth rate (CAGR), from $348.92M to $291.05M.